United Parcel Service Inc Chief Executive Carol Tomé stated that the company's strategy of aggressively expanding its high-margin prescription drug delivery business will serve as an effective hedge against economic uncertainties, such as a potential U.S.-Israel war with Iran.
In an interview, Tomé pointed out that unlike cyclical sectors such as retail, residential, or manufacturing, the healthcare logistics business exhibits stronger recession-resistant characteristics. Even amid conflicts involving Iran that threaten the global economic outlook, healthcare demand continues to grow steadily. "The past few years have seen numerous challenges, including high inflation and market contractions, yet healthcare continues to grow. I believe the healthcare sector is largely insulated from recessions," Tomé said.
Prescription drug delivery has long been a cornerstone of United Parcel Service Inc's multi-year transformation strategy. The company is actively restructuring its network, reducing the volume of low-margin packages from clients like Amazon, and reallocating resources toward higher-margin segments. Tomé revealed that United Parcel Service Inc has achieved its first-ever quarterly healthcare revenue exceeding $1 billion, with full-year healthcare revenue reaching $11.2 billion in 2025, accounting for nearly 13% of consolidated revenue.
Compared to e-commerce delivery, which typically yields single-digit profit margins, healthcare logistics offers significantly higher profitability. For instance, temperature-controlled pharmaceutical delivery can achieve mid-to-high teen percentage margins. United Parcel Service Inc has constructed approximately 100,000 square feet of customized laboratory space near its Louisville headquarters, leased to healthcare companies for rapid processing of test samples under leases exceeding ten years. The company aims to double its healthcare revenue to $20 billion by 2026 and become a global leader in complex healthcare logistics.
However, analysts are monitoring a vulnerable segment within United Parcel Service Inc's healthcare business: the home delivery of GLP-1 weight-loss drugs paid for directly by consumers. This segment could face demand contraction during an economic downturn.